RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (9)
Sanyal, Nilotpal
Evidence for the role of gonadotropin hormones in the development of Alzheimer disease.
Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells.
Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data.
Estrogen replacement and risk of Alzheimer disease.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Estrogen replacement and risk of Alzheimer disease.
Smith MA, Perry G, Atwood CS, Bowen RL. Estrogen replacement and risk of Alzheimer disease. JAMA. 2003 Mar 05; 289(9):1100; author reply 1101-2.
View in:
PubMed
subject areas
Alzheimer Disease
Estrogen Replacement Therapy
Estrogens
Female
Gonadotropins
Humans
Postmenopause
Risk Factors
authors with profiles
George Perry